nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
|
Roep, Bart O |
|
2019 |
7 |
1 |
p. 65-74 |
artikel |
2 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 34–43
|
|
|
2019 |
7 |
1 |
p. e1 |
artikel |
3 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 25–33
|
|
|
2019 |
7 |
1 |
p. e1 |
artikel |
4 |
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study
|
Samelson, Elizabeth J |
|
2019 |
7 |
1 |
p. 34-43 |
artikel |
5 |
Distinguishing remnant ablation from adjuvant treatment in differentiated thyroid cancer
|
Tuttle, R Michael |
|
2019 |
7 |
1 |
p. 7-8 |
artikel |
6 |
Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial
|
Dodd, Jodie M |
|
2019 |
7 |
1 |
p. 15-24 |
artikel |
7 |
Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
|
Basu, Sanjay |
|
2019 |
7 |
1 |
p. 25-33 |
artikel |
8 |
Evidence of hypothyroidism in a portrait by Lorenzo Lotto
|
Asensi, Víctor |
|
2019 |
7 |
1 |
p. 14 |
artikel |
9 |
Improving fracture risk assessment in older adults
|
Shane, Elizabeth |
|
2019 |
7 |
1 |
p. 5-7 |
artikel |
10 |
Insulin use for type 2 diabetes: the challenges of predicting trends and modelling care
|
Gerstein, Hertzel C |
|
2019 |
7 |
1 |
p. 4-5 |
artikel |
11 |
Liothyronine cost and prescriptions in England
|
Taylor, Peter N |
|
2019 |
7 |
1 |
p. 11-12 |
artikel |
12 |
Novel subgroups of patients with adult-onset diabetes in Chinese and US populations
|
Zou, Xiantong |
|
2019 |
7 |
1 |
p. 9-11 |
artikel |
13 |
Reassessing strategies to improve pregnancy outcomes in overweight and obese women
|
Catalano, Patrick M |
|
2019 |
7 |
1 |
p. 2-3 |
artikel |
14 |
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
|
Dehbi, Hakim-Moulay |
|
2019 |
7 |
1 |
p. 44-51 |
artikel |
15 |
Research in brief
|
McIntosh, Kate V |
|
2019 |
7 |
1 |
p. 13 |
artikel |
16 |
The challenge of modulating β-cell autoimmunity in type 1 diabetes
|
Atkinson, Mark A |
|
2019 |
7 |
1 |
p. 52-64 |
artikel |
17 |
Type 1 diabetes research: poised for progress
|
The Lancet Diabetes & Endocrinology, |
|
2019 |
7 |
1 |
p. 1 |
artikel |